Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

FLACU - Frazier Lifesciences Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)


Close
9.5
0.230   2.420%

Share volume: 0
Last Updated: Tue 22 Nov 2022 10:00:00 PM CET

PREVIOUS CLOSE
CHG
CHG%

$9.27
0.23
2.48%
This ticker is disabled and data are no longer maintained and up to date.
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$9.50
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
7.625 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website: frazierlifesciencesacquisition.com
Employees: 4
IPO year: -
Issue type:
Market: XNAS
Industry:
Sector:

Frazier Lifesciences Acquisition Corporation, sponsored by a Cayman Islands affiliate of Frazier Life Sciences X, L.P., is a newly incorporated blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. Frazier Lifesciences Acquisition Corporation expects that its focus will be on the biotechnology sector in developed countries including, but not limited to, the United States and countries in Europe.

Recent news